©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Oct 16, 2016; 4(10): 323-327
Published online Oct 16, 2016. doi: 10.12998/wjcc.v4.i10.323
Published online Oct 16, 2016. doi: 10.12998/wjcc.v4.i10.323
Greater occipital nerve blocks in the treatment of refractory chronic migraine: An observational report of nine cases
Abdulkadir Koçer, Department of Neurology, Göztepe Teaching Hospital, Istanbul Medeniyet University Medical Faculty, 34100 Istanbul, Turkey
Author contributions: Koçer A planned and wrote the paper.
Institutional review board statement: No need.
Informed consent statement: All study participants provided informed written consent prior to injections.
Conflict-of-interest statement: Nothing to be declared.
Data sharing statement: No additional data are available.
Correspondence to: Abdulkadir Koçer, MD, MSc, Profesor of Neurology, Department of Neurology, Göztepe Teaching Hospital, Istanbul Medeniyet University Medical Faculty, Erkin Street, Number 4, 34100 Istanbul, Turkey. abdulkadirkocer@yahoo.com
Telephone: +90-50-54262828 Fax: +90-21-65709050
Received: April 29, 2016
Peer-review started: April 29, 2016
First decision: June 17, 2016
Revised: July 21, 2016
Accepted: August 6, 2016
Article in press: August 8, 2016
Published online: October 16, 2016
Processing time: 168 Days and 5.4 Hours
Peer-review started: April 29, 2016
First decision: June 17, 2016
Revised: July 21, 2016
Accepted: August 6, 2016
Article in press: August 8, 2016
Published online: October 16, 2016
Processing time: 168 Days and 5.4 Hours
Core Tip
Core tip: In this observational study, we report the results of 9 patients with refractory chronic migraine. The greater occipital nerve block with lidocaine seems to be one of the reliable treatment methods for the transitional treatment of refractory chronic migraine in order to take them back toward non-refractoriness which can be easily solved by the preventive therapies conventionally accepted. We think that this procedure can be effective in refractory migraine cases and should be included in our management plan.